The Question of Accuracy Versus Interlaboratory Agreement for Monitoring the Immunosuppressants Everolimus and Sirolimus

Ther Drug Monit. 2021 Jun 1;43(3):444-446. doi: 10.1097/FTD.0000000000000892.

Authors

Cato Brede¹, Nils T Vethe², Øyvind Skadberg¹

Affiliations

¹ Department of Medical Biochemistry, Stavanger University Hospital, Stavanger.
² Department of Pharmacology, Oslo University Hospital, Oslo, Norway.

PMID: 33840796
DOI: 10.1097/FTD.0000000000000892

No abstract available

MeSH terms

Drug Monitoring / standards*
Everolimus* / pharmacokinetics
Humans
Immunosuppressive Agents* / pharmacokinetics
Laboratories / standards
Sirolimus* / pharmacokinetics

Substances

Immunosuppressive Agents
Everolimus
Sirolimus